-
1 Comment
IQ-AI Limited is currently in a long term downtrend where the price is trading 5.9% below its 200 day moving average.
From a valuation standpoint, the stock is 89.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 44.9.
Based on the above factors, IQ-AI Limited gets an overall score of 1/5.
| Exchange | LSE |
|---|---|
| CurrencyCode | GBP |
| ISIN | JE00BD4H0R42 |
| Sector | Healthcare |
| Industry | Health Information Services |
| Target Price | 63.25 |
|---|---|
| Market Cap | 2M |
| Beta | 2.71 |
| PE Ratio | None |
| Dividend Yield | None |
IQ-AI Limited, through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States. It develops ready-to-use software applications for the healthcare industry; and provides technology solutions in the field of kidney stone analysis and prevention, as well as offers consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. The company was incorporated in 1965 and is based in Saint Helier, Jersey.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IQAI.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
